Kommentar zur neuen Leitlinie Akuttherapie und Management der Anaphylaxie 2021

M. Worm; J. Ring

doi:10.5414/ALX02242

Kommentar zur neuen Leitlinie Akuttherapie und Management der Anaphylaxie 2021

Translated title of the contribution: Commentary on the new guideline for acute therapy and management of anaphylaxis 2021

M. Worm, J. Ring

Default

Charité – Universitätsmedizin Berlin

Research output: Contribution to journal › Comment/debate

Translated title of the contribution	Commentary on the new guideline for acute therapy and management of anaphylaxis 2021
Original language	German
Pages (from-to)	318-322
Number of pages	5
Journal	Allergologie
Volume	44
Issue number	4
DOIs	https://doi.org/10.5414/ALX02242
State	Published - Apr 2021

Access to Document

10.5414/ALX02242

Cite this

@article{6c8fefa7bd204184bd5adecc973dcfa4,

title = "Kommentar zur neuen Leitlinie Akuttherapie und Management der Anaphylaxie 2021",

keywords = "Adrenalin-autoinjector, Anaphylaxis, cofactors, Anaphylaxis, elicitors",

author = "M. Worm and J. Ring",

year = "2021",

month = apr,

doi = "10.5414/ALX02242",

language = "Deutsch",

volume = "44",

pages = "318--322",

journal = "Allergologie",

issn = "0344-5062",

publisher = "Dustri-Verlag Dr. Karl Feistle",

number = "4",

}

TY - JOUR

T1 - Kommentar zur neuen Leitlinie Akuttherapie und Management der Anaphylaxie 2021

AU - Worm, M.

AU - Ring, J.

PY - 2021/4

Y1 - 2021/4

KW - Adrenalin-autoinjector

KW - Anaphylaxis, cofactors

KW - Anaphylaxis, elicitors

UR - http://www.scopus.com/inward/record.url?scp=85104739633&partnerID=8YFLogxK

U2 - 10.5414/ALX02242

DO - 10.5414/ALX02242

M3 - Kommentar/Debatte

AN - SCOPUS:85104739633

SN - 0344-5062

VL - 44

SP - 318

EP - 322

JO - Allergologie

JF - Allergologie

IS - 4

ER -

Kommentar zur neuen Leitlinie Akuttherapie und Management der Anaphylaxie 2021

Access to Document

Other files and links

Cite this